115 related articles for article (PubMed ID: 18396639)
1. [Inhibitory effect of oxaliplatin in combination with hyperthermia on angiogenesis].
Qian XP; Liu BR; Li M; Hu J; Hu WJ; Zou ZY; Wang LF; Yu LX
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):826-9. PubMed ID: 18396639
[TBL] [Abstract][Full Text] [Related]
2. [Anti-angiogenic effect of vinorelbine in combination with cetuximab in vitro and in vivo].
Qian XP; Liu BR; Wan L; Hu J; Zhu LJ; Yu LX
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):253-7. PubMed ID: 20510073
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic effect of a Palladium(II)-Saccharinate Complex of Terpyridine in vitro and in vivo.
Ikitimur-Armutak EI; Gurel-Gurevin E; Kiyan HT; Aydinlik S; Yilmaz VT; Dimas K; Ulukaya E
Microvasc Res; 2017 Jan; 109():26-33. PubMed ID: 27613574
[TBL] [Abstract][Full Text] [Related]
4. Taspine isolated from Radix et Rhizoma Leonticis inhibits proliferation and migration of endothelial cells as well as chicken chorioallantoic membrane neovascularisation.
Zhang Y; He L; Meng L; Luo W
Vascul Pharmacol; 2008; 48(2-3):129-37. PubMed ID: 18304881
[TBL] [Abstract][Full Text] [Related]
5. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
[TBL] [Abstract][Full Text] [Related]
7. Endostar, a modified recombinant human endostatin, exhibits synergistic effects with dexamethasone on angiogenesis and hepatoma growth.
Li XQ; Shang BY; Wang DC; Zhang SH; Wu SY; Zhen YS
Cancer Lett; 2011 Feb; 301(2):212-20. PubMed ID: 21216091
[TBL] [Abstract][Full Text] [Related]
8. [In vitro anti-angiogenic action of lambda-carrageenan oligosaccharides].
Chen HM; Yan XJ; Wang F; Lin J; Xu WF
Yao Xue Xue Bao; 2007 Jun; 42(6):595-600. PubMed ID: 17702394
[TBL] [Abstract][Full Text] [Related]
9. Vascular disrupting activity of combretastatin analogues.
Porcù E; Salvador A; Primac I; Mitola S; Ronca R; Ravelli C; Bortolozzi R; Vedaldi D; Romagnoli R; Basso G; Viola G
Vascul Pharmacol; 2016 Aug; 83():78-89. PubMed ID: 27235861
[TBL] [Abstract][Full Text] [Related]
10. [Effect of triptolide on expression of urokinase-type plasminogen activators in vascular endothelial cells].
Ding Y; Zhang J; Zhao QL; Hou LJ; Wang QL; Wang SR
Ai Zheng; 2005 Jul; 24(7):801-5. PubMed ID: 16004804
[TBL] [Abstract][Full Text] [Related]
11. Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo.
Kunimasa K; Ikekita M; Sato M; Ohta T; Yamori Y; Ikeda M; Kuranuki S; Oikawa T
Cancer Sci; 2010 Nov; 101(11):2462-9. PubMed ID: 20670297
[TBL] [Abstract][Full Text] [Related]
12. Low-dose metronomic chemotherapy with cisplatin: can it suppress angiogenesis in H22 hepatocarcinoma cells?
Shen FZ; Wang J; Liang J; Mu K; Hou JY; Wang YT
Int J Exp Pathol; 2010 Feb; 91(1):10-6. PubMed ID: 20096070
[TBL] [Abstract][Full Text] [Related]
13. Dihydrotanshinone I inhibits angiogenesis both in vitro and in vivo.
Bian W; Chen F; Bai L; Zhang P; Qin W
Acta Biochim Biophys Sin (Shanghai); 2008 Jan; 40(1):1-6. PubMed ID: 18180848
[TBL] [Abstract][Full Text] [Related]
14. [Anti-angiogenetic effect of arenobufagin in vitro and in vivo].
Liu JS; Zhang DM; Chen MF; Li MM; Luo QD; Kurihara H; Ye WC
Yao Xue Xue Bao; 2011 May; 46(5):527-33. PubMed ID: 21800539
[TBL] [Abstract][Full Text] [Related]
15. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
[TBL] [Abstract][Full Text] [Related]
16. Danshensu has anti-tumor activity in B16F10 melanoma by inhibiting angiogenesis and tumor cell invasion.
Zhang LJ; Chen L; Lu Y; Wu JM; Xu B; Sun ZG; Zheng SZ; Wang AY
Eur J Pharmacol; 2010 Sep; 643(2-3):195-201. PubMed ID: 20621088
[TBL] [Abstract][Full Text] [Related]
17. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
Gao W; Jin K; Lan H; Han N; Cao F; Teng L
Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
[TBL] [Abstract][Full Text] [Related]
19. The antiangiogenic effects of polyisoprenylated cysteinyl amide inhibitors in HUVEC, chick embryo and zebrafish is dependent on the polyisoprenyl moiety.
Nkembo AT; Ntantie E; Salako OO; Amissah F; Poku RA; Latinwo LM; Lamango NS
Oncotarget; 2016 Oct; 7(42):68194-68205. PubMed ID: 27626690
[TBL] [Abstract][Full Text] [Related]
20. Neridronate inhibits angiogenesis in vitro and in vivo.
Ribatti D; Nico B; Mangieri D; Maruotti N; Longo V; Vacca A; Cantatore FP
Clin Rheumatol; 2007 Jul; 26(7):1094-8. PubMed ID: 17106617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]